# AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics (ANTX) sees a surge in social dominance and positive sentiment, but faces challenges with declining engagements and mentions. A top post highlights community involvement and a fair launch for $ANTX token.

### About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for infectious diseases.  
AN2 Therapeutics, Inc. uses the ticker $ANTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- AN2 Therapeutics, Inc. (ANTX) social dominance is up 366.67% from the previous month.
- AN2 Therapeutics, Inc. (ANTX) sentiment is up 15.15% from the previous week.
- AN2 Therapeutics, Inc. (ANTX) creators is up 14.29% from the previous week.
- AN2 Therapeutics, Inc. (ANTX) engagements is up 192.56% from the previous week.
- AN2 Therapeutics, Inc. (ANTX) mentions is up 69.7% from the previous week.
- AN2 Therapeutics, Inc. (ANTX) posts created is up 200% from the previous week.

### Price: $1.10
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$antx/time-series/close.tsv)  
The current price of $1.10, hitting a 52-week low, is likely influenced by the surge in trading volume and positive sentiment. However, the sharp decline in engagements and mentions suggests that this upward momentum may not be sustainable without renewed social interest.  

24-Hour: 0.95%
7-Day: -4.5%
30-Day: -11.67%

1-Year High: $1.40 on 2025-10-27  
1-Year Low: $1.10 on 2025-07-01  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$antx/time-series/alt_rank.tsv)  
AN2 Therapeutics, Inc. (ANTX) is currently AltRank #2,208 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +368  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [-----] on 2026-01-24  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$antx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] no change  
1-Year High: [--] on 2025-03-27  
1-Year Low: [--] on 2025-05-03  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$antx/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] +193%  
[--] Month: [------] +87%  
[--] Months: [-------] -56%  
[--] Year: [-------] -53%  
1-Year High: [------] on 2025-05-07  
1-Year Low: [--] on 2025-10-11  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$antx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +70%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-27  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$antx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning AN2 Therapeutics, Inc. (ANTX) in the last [--] hours which is up 40% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +14%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-27  

The most influential creators that mention AN2 Therapeutics, Inc. in the last [--] hours

| Creator                                      | Rank | Followers | Posts | Engagements |
| -------                                      | ---- | --------- | ----- | ----------- |
| [@Ori_the_Ant](/creator/twitter/Ori_the_Ant) | [--]    | [---]       | [--]     | [--]           |

[View More](/list/creators/$antx/100)
  
  
### Sentiment: 40%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$antx/time-series/sentiment.tsv)  
Current Value: 40%  
Daily Average: 86%  
[--] Week: 38% +5%  
[--] Month: 50% -50%  
[--] Months: 50% -43%  
[--] Year: 50% -50%  
1-Year High: 100% on 2025-02-16  
1-Year Low: 14% on 2025-05-07  

Most Supportive Themes:
- Galaxy Score™ Surge: (30%) The Galaxy Score™ has seen a significant increase of 30.43% from the previous week, reaching a 52-week high of [--]. This indicates a strong positive trend in the company's overall social and market metrics.
- Sentiment Improvement: (60%) Sentiment has surged by 150% from the previous week, reaching 100% for the week. This suggests a highly positive outlook from the social community regarding AN2 Therapeutics.
- Social Dominance Increase: (1%) Social dominance has increased by 0.0006% from the previous week, indicating a growing presence in social media conversations. The current value is 0.0007986510783287027%.
  
Most Critical Themes:
- Low Engagements: (-98%) Current engagements are at [--] (24h), a significant drop from the daily average of [-----]. This low engagement, despite positive sentiment, could hinder sustained price momentum.
- Decreased Mentions and Creators: (-40%) Mentions have decreased by 31% over the week to [--] (24h), and active creators are down 50% to [--] (24h). This reduction in social activity could impact visibility and future interest.
  
  
  
### Social Dominance: 0.00167%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$antx/time-series/social_dominance.tsv)  
Current Value: 0.00167%  
Daily Average: 0.00259%  
[--] Week: 0.00147% +0.0004999999999999999%  
[--] Month: 0.0028% +0.0022%  
[--] Months: 0.0028% -0.0009000000000000002%  
[--] Year: 0.0028% +0.00009999999999999983%  
1-Year High: 0.03% on 2025-06-29  
1-Year Low: 0.0001% on 2025-09-27  
  
  
### Market Dominance: 0.00003289442559547888%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$antx/time-series/market_dominance.tsv)  
Current Value: 0.00003289442559547888%  
Daily Average: 0%  
1-Year High: 0.00138% on 2026-02-06  
1-Year Low: 0.00003% on 2026-02-15  
  
  
### Market Cap: $29,046,145
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$antx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$antx/time-series/market_cap.tsv)  
Current Value: $29,046,145  
Daily Average: $31,355,169  
[--] Week: $29,046,145 -4.50%  
[--] Month: $29,046,145 -15%  
1-Year High: $35,896,651 on 2026-01-14  
1-Year Low: $28,772,125 on 2026-02-12  

### Top AN2 Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Had the privilege of getting to know and watch @Ori_the_Ant dev this past year. Before I jumped into his creative madness hed pop into the @KasPunks TG chat every so often with fresh drawings from his ANTX projects. A bunch of us punks soon joined the minting frenzy for $ANTX token which has since expanded into @zmemes_antx_kas and ZxCap. @kinetikz_33s energy has been consistent since day one: laser focused dedication to his craft while simultaneously pushing for Kaspunks' success. Yesterday a few whitelisters and I took part in what felt like the fairest launch to ever exist. @kinetikz_33"  
[X Link](https://x.com/ltruongyeg/status/2022813271959703847) [@ltruongyeg](/creator/x/ltruongyeg) 2026-02-14T23:20Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing